Publication Brief
Advancing immuno-oncology research requires precise tools to measure key biomarkers like cytokines, which play a central role in the immune response to cancer therapies. Clinical responses to immunotherapies can vary widely, highlighting the need for ultra-sensitive assays to track subtle cytokine changes.
Simoa® digital immunoassays provide unparalleled sensitivity and reproducibility, empowering researchers to quantify low-abundance cytokines and gain critical insights into treatment efficacy and safety. This publication brief explores the power of Simoa® technology in immuno-oncology, featuring its impact on biomarker discovery and monitoring for improved cancer treatment outcomes.